Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer
Robert D. Frisina(Oslo University Hospital), Lois B. Travis(Indiana University – Purdue University Indianapolis), Darren R. Feldman(Memorial Sloan Kettering Cancer Center), Patrick O. Monahan(Regenstrief Institute), Shirin Ardeshir‐Rouhani‐Fard(Oslo University Hospital), David J. Vaughn(American Society of Clinical Oncology), Amy Budnick(Oslo University Hospital), Lawrence H. Einhorn(Eastern Cooperative Oncology Group), M. Eileen Dolan(University of Chicago), Heather E. Wheeler(Memorial Sloan Kettering Cancer Center), Sophie D. Fosså(Norwegian Cancer Society), Chunkit Fung(Oslo University Hospital), Steven E. Lipshultz, Sarah L. Kerns, Robert J. Hamilton(Oslo University Hospital), Howard D. Sesso(Brigham and Women's Hospital), Clair J. Beard(Oslo University Hospital), Eileen Johnson(Texas Tech University)
Cited by 280
Related Papers
Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection
|Annals of Internal Medicine|2007|4.8k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
|The Lancet|2008|873
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
|JNCI Journal of the National Cancer Institute|2005|830